-
Editor's note: This is part one of our coverage of a presentation on mentoring by Carolyn E. Jackson, RN, MA, CIC, infection preventionist at SHW Hadley Hospital and Skilled Nursing Facility in Washington, DC. Jackson spoke recently in New Orleans at the annual conference of the Association for Professionals in Infection Control and Epidemiology (APIC). For part two of this story, see the next installment of Wisdom Teachers.
-
Squaring off with the nation's leading infection prevention groups, health care worker unions and associations are urging the Occupational Safety and Health Administration (OSHA) to develop an infectious disease standard that would essentially regulate and enforce infection control programs in hospitals.
-
More health care workers received the flu vaccine last season than ever before, but that has not eased the pressure to boost immunization rates.
-
Many will have an opinion, yet the question in the headline cannot be definitively answered. I will not attempt to solve the debate, but let me try to shed a little light on it.
-
-
A recent report described a fatal case of community-acquired C. difficile diarrhea (CDAD) in a patient receiving antibiotics for a questionable diagnosis of chronic Lyme disease.
-
A retrospective cohort study was conducted of infants < 6 months of age hospitalized with urinary tract infections between 1999 and 2004 at 24 children's hospitals in the United States.
-
In March 2009, 89 active-duty u.s. trainees received yellow fever (YF) vaccination as part of standard preparation for potential travel to sub-Saharan Africa and Central and South America.
-
A retrospective observational study was conducted on 30 individuals from a possible 49 persons who were treated for schistosomiasis between 2003 and 2008 at Copenhagen University Hospital, Denmark.
-
This subset analysis from a larger prospective, multicenter HIV-HCV coinfection treatment trial found that patients receiving highly active antiretroviral therapy (HAART) in combination with pegylated interferon alfa and ribavirin for HCV were at greater risk for lactic acidosis and hyperlactatemia than those receiving HCV treatment alone.
